1. Home
  2. GNTY vs PRTC Comparison

GNTY vs PRTC Comparison

Compare GNTY & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNTY
  • PRTC
  • Stock Information
  • Founded
  • GNTY 1913
  • PRTC 2015
  • Country
  • GNTY United States
  • PRTC United States
  • Employees
  • GNTY N/A
  • PRTC N/A
  • Industry
  • GNTY Major Banks
  • PRTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • GNTY Finance
  • PRTC Health Care
  • Exchange
  • GNTY Nasdaq
  • PRTC Nasdaq
  • Market Cap
  • GNTY 434.5M
  • PRTC 439.8M
  • IPO Year
  • GNTY 2017
  • PRTC N/A
  • Fundamental
  • Price
  • GNTY $43.28
  • PRTC $17.94
  • Analyst Decision
  • GNTY Buy
  • PRTC Buy
  • Analyst Count
  • GNTY 2
  • PRTC 1
  • Target Price
  • GNTY $41.00
  • PRTC $45.00
  • AVG Volume (30 Days)
  • GNTY 41.6K
  • PRTC 2.4K
  • Earning Date
  • GNTY 07-14-2025
  • PRTC 04-30-2025
  • Dividend Yield
  • GNTY 2.31%
  • PRTC N/A
  • EPS Growth
  • GNTY 18.89
  • PRTC N/A
  • EPS
  • GNTY 2.91
  • PRTC 0.21
  • Revenue
  • GNTY $123,780,000.00
  • PRTC $4,828,000.00
  • Revenue This Year
  • GNTY $10.99
  • PRTC $35.98
  • Revenue Next Year
  • GNTY $4.68
  • PRTC $115.38
  • P/E Ratio
  • GNTY $14.84
  • PRTC $7.92
  • Revenue Growth
  • GNTY 4.44
  • PRTC 44.98
  • 52 Week Low
  • GNTY $28.57
  • PRTC $13.30
  • 52 Week High
  • GNTY $43.29
  • PRTC $26.79
  • Technical
  • Relative Strength Index (RSI)
  • GNTY 65.44
  • PRTC 48.72
  • Support Level
  • GNTY $40.02
  • PRTC $17.32
  • Resistance Level
  • GNTY $42.41
  • PRTC $18.06
  • Average True Range (ATR)
  • GNTY 1.13
  • PRTC 0.44
  • MACD
  • GNTY 0.18
  • PRTC -0.20
  • Stochastic Oscillator
  • GNTY 97.31
  • PRTC 43.64

About GNTY Guaranty Bancshares Inc.

Guaranty Bancshares Inc is a bank holding company conducting banking activities through its wholly-owned subsidiary. The company provides its customers with a full array of relationship-driven commercial and consumer banking products and services, as well as mortgage, trust, and wealth management products and services that are tailored to meet the needs of small and medium-sized businesses, professionals, and individuals. It also provides other services such as Credit cards, Personal Loans, Business Checking, Treasury Management, and other related services. The company generates its revenue from interest on loans and investments, customer service and loan fees, fees related to the sale of mortgage loans, and trust and wealth management services.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: